Evidence map›Paper›PMID 37999956›Full record

ArticleeLife2023

SUMOylation of Bonus, the

Baira Godneeva, Maria Ninova, Katalin Fejes-Toth, Alexei Aravin

Open access · goldAbstract read
In one paragraph

Article in eLife, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.9field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 6 citations in OpenAlex.

  1. Yorkie/YAP Interactors: Fine-Tuning the Hippo Pathway Output.Cold Spring Harbor perspectives in biology · 2026
    Article
  2. The Many Faces of SetDB1.Epigenomes · 2026
    Review
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors at 1 institution in 2 countries.

Baira GodneevaCalifornia Institute of Technology, Division of Biology and Biological Engineering, Pasadena, United States.ORCID 0009-0004-1662-8844
Maria NinovaUniversity of California, Riverside, Riverside, United States.
Katalin Fejes-TothCalifornia Institute of Technology, Division of Biology and Biological Engineering, Pasadena, United States.
Alexei AravinCalifornia Institute of Technology, Division of Biology and Biological Engineering, Pasadena, United States.ORCID 0000-0002-6956-8257
University of California, Riverside · US

Funding

Molecular Mechanism of the piRNA BiogenesisR01GM097363 · NIGMS · CORNELL UNIVERSITY · PI ARAVIN, ALEXEI A. · 2011 to 2025
$4.0M
Understanding the mechanism of Piwi-induced transcriptional silencingR01GM110217 · NIGMS · CALIFORNIA INSTITUTE OF TECHNOLOGY · PI FEJES TOTH, KATALIN · 2014 to 2024
$3.1M
Elucidating the role of SUMO ligase Su(var)2-10 in piRNA-guided transcriptional silencing and repressive chromatin formationR00HD099316 · NICHD · UNIVERSITY OF CALIFORNIA RIVERSIDE · PI NINOVA, MARIA ANTONINOVA · 2021 to 2023
$712k
Elucidating the role of SUMO ligase Su(var)2-10 in piRNA-guided transcriptional silencing and repressive chromatin formationK99HD099316 · NICHD · CALIFORNIA INSTITUTE OF TECHNOLOGY · PI NINOVA, MARIA ANTONINOVA · 2019 to 2020
$259k
Howard Hughes Medical Institute Faculty Scholar AwardNICHD NIH HHS K99 HD099316NICHD NIH HHS R00 HD099316NIGMS NIH HHS R01 GM097363NIGMS NIH HHS R01 GM110217NIH HHS R00 HD099316NIH HHS R01 GM097363NIH HHS R01 GM110217
6 · The paper itself

Abstract

The conserved family of Transcription Intermediary Factors (TIF1) proteins consists of key transcriptional regulators that control transcription of target genes by modulating chromatin state. Unlike mammals that have four TIF1 members,

Indexed as

ChromatinDrosophila ProteinsAnimalsDrosophilaFemaleGerm CellsMammalsMediation AnalysisNuclear ProteinsSumoylationTranscription FactorsBon protein, DrosophilaChromatinDrosophila ProteinsNuclear Proteinstranscriptional intermediary factor 1Transcription FactorschromosomesD. melanogastergene expressiongeneticsgenomicsgerm cellsheterochromatinSUMOtranscriptional regulation

Identifiers

PMID37999956
PMCPMC10672805
OpenAlexW4386460572

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.